Utilising accessible and reproducible neurological assessments in clinical studies: Insights from use of the Neurological Impairment Scale in the multi-centre COVID-CNS study
Alam AM. et al, (2024), Clinical Medicine, Journal of the Royal College of Physicians of London, 24
Re: Shahim et al., 2024 cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.
Tamborska AA. et al, (2024), Eur Heart J Cardiovasc Pharmacother
Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study
Tamborska AA. et al, (2023), Journal of the Neurological Sciences, 449
Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Liu YCC. et al, (2023), Vaccine, 41, 1902 - 1910
A clinical approach to the investigation and management of long COVID associated neuropathic pain
Shil RSK. et al, (2023), European Archives of Psychiatry and Clinical Neuroscience
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports
Garcia-Azorin D. et al, (2022), Cephalalgia, 42, 1207 - 1217
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform
Walker JL. et al, (2022), Vaccine, 40, 4479 - 4487
Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: A prospective surveillance study
Tamborska AA. et al, (2022), BMJ Neurology Open, 4
Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Frontera JA. et al, (2022), Annals of Neurology, 91, 756 - 771
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
Singh B. et al, (2022), PLoS ONE, 17
COVID-19 vaccine associated demyelination & its association with MOG antibody
Netravathi M. et al, (2022), Multiple Sclerosis and Related Disorders, 60
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: From cerebral venous sinus thrombosis to functional neurological disorder
Butler M. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry, 92, 1144 - 1151
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Perry RJ. et al, (2021), The Lancet, 398, 1147 - 1156
Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions
Thakur KT. et al, (2021), Journal of the Neurological Sciences, 427
Prognostic Indicators and Outcomes of Hospitalised COVID-19 Patients with Neurological Disease: A Systematic Review and Individual Patient Data Meta-Analysis
Singh B. et al, (2021), SSRN Electronic Journal
Evaluation of appendicitis risk prediction models in adults with suspected appendicitis
Bhangu A. et al, (2020), British Journal of Surgery, 73 - 86
Non-invasive measurement of fasciculation frequency demonstrates diagnostic accuracy in amyotrophic lateral sclerosis
Tamborska A. et al, (2020), Brain Communications, 2
Mitochondrial DNA is a pro-inflammatory damage-associated molecular pattern released during active IBD
Boyapati RK. et al, (2018), Inflammatory Bowel Diseases, 24, 2113 - 2122
Characteristics of randomized trials focusing on stroke due to intracerebral hemorrhage systematic review
Tamborska A. et al, (2018), Stroke, 49, 594 - 600
Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases
Ho GT. et al, (2017), F1000Research, 6